RAPS Convergence is the largest and most recognized annual gathering of global regulatory affairs professionals. Convergence brings together representatives of industry, regulatory bodies, research, academia, and clinical organizations that are directly involved in managing the regulatory process and aligning science, regulation, and business strategy.
TransCelerate’s plenary panel “Progressing Patient-Centered Health through Collaboration: A TransCelerate Multi-Stakeholder Panel” features panelists:
- Ginny Beakes-Read, Executive Director, Global Regulatory and R&D Policy, Amgen
- Janice Chang, CEO, TransCelerate BioPharma
- Christine Mayer-Nicolai, Vice President, Head Global Regulatory and Scientific Policy, Merck
- Dr. Janet Woodcock, Principal Deputy Commissioner, U.S. Food & Drug Administration